Literature DB >> 4030980

Determination of the serum concentration of spironolactone and its metabolites by high-performance liquid chromatography.

J W Overdiek, W A Hermens, F W Merkus.   

Abstract

A simple and rapid high-performance liquid chromatographic assay is described for the simultaneous determination in serum of the aldosterone antagonist spironolactone and its metabolites 7 alpha-thiomethylspirolactone, 6 beta-hydroxy-7 alpha-thiomethylspirolactone and canrenone. Ultraviolet absorption at 240 nm was used to detect the different compounds after elution on a normal-phase column. Endogenous serum substances did not interfere with the assay. This method provides a convenient tool in pharmacokinetic studies of spironolactone, in contrast to previously reported aspecific fluorimetric assays or time-consuming thin-layer chromatographic analyses of radioactive biological material.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030980     DOI: 10.1016/s0378-4347(00)84041-4

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone.

Authors:  Miranda E Good; Yu-Hsin Chiu; Ivan K H Poon; Christopher B Medina; Joshua T Butcher; Suresh K Mendu; Leon J DeLalio; Alexander W Lohman; Norbert Leitinger; Eugene Barrett; Ulrike M Lorenz; Bimal N Desai; Iris Z Jaffe; Douglas A Bayliss; Brant E Isakson; Kodi S Ravichandran
Journal:  Circ Res       Date:  2017-12-13       Impact factor: 17.367

2.  Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.

Authors:  I Terai; K Yamano; N Ichihara; J Arai; K Kobayashi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

3.  Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.

Authors:  A Hedman; B Angelin; A Arvidsson; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Improved bioavailability from a spironolactone beta-cyclodextrin complex.

Authors:  N T Yusuff; P York; H Chrystyn; P N Bramley; R D Swallow; B R Tuladhar; M S Losowsky
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.